Evidence map›Paper›PMID 41983701›Full record

ArticlemBio2026

γ-Butyrolactone-induced coelimycin synthesis inhibits AtrA-dependent actinorhodin overproduction in

Bartosz Bednarz, Magdalena Kotowska, Mateusz Wenecki, Michał Tracz, Marta Derkacz, Adrianna Jastrzemska, Jarosław Ciekot, Lizaveta Karpovich, Krzysztof Pawlik

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bartosz BednarzLaboratory of Biological Chemistry, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID 0000-0003-3983-5868
Magdalena KotowskaPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.ORCID 0000-0002-5000-454X
Mateusz WeneckiPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.ORCID 0000-0002-3770-0102
Michał TraczLaboratory of Mass Spectrometry, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland.ORCID 0000-0001-7510-5024
Marta DerkaczPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Adrianna JastrzemskaPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Jarosław CiekotPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Lizaveta KarpovichPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Krzysztof PawlikPolish Academy of Sciences, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.ORCID 0000-0002-5881-9292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

4-ButyrolactoneAnthraquinonesAnti-Bacterial AgentsStreptomyces coelicolorBacterial ProteinsBenzoisochromanequinonesBiosynthetic PathwaysGene Expression Regulation, BacterialMultigene FamilySecondary Metabolism4-ButyrolactoneactinorhodinAnthraquinonesAnti-Bacterial AgentsBacterial ProteinsBenzoisochromanequinonesactinorhodinantibiotic biosynthesis regulationcoelimycinquorum sensingsecondary metabolismStreptomycesTetR familyγ-butyrolactones

Identifiers

PMID41983701
PMCPMC13170358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.